semaglutide 2 months on Ozempic for Weight Loss - GLP-1 Appetite Suppressant Semaglutide | Results Weight Loss

doi: 10.1210/endo.139.4.5921 48 NauckMABartelsEOrskovCEbertRCreutzfeldtW

Nutritional risk during GLP-1 therapy is primarily intake-driven rather than malabsorptive in origin

GLP-1 RA have also been demonstrated to reduce EAT thickness, suppress RAAS activation, improve myocardial energy metabolism, and attenuate systemic inflammation and cardiac oxidative stress [137139]

Additional regulatory documents were screened from the FDA, EMA, and WHO databases

The results have prompted a clinical trial to determine whether the association reflects a true protective effect

Antidiabetic drugs like Ozempic are not covered for obesity, so most health insurance covers it for treating diabetes only